Skip to content
10-Q

Quarterly Report

UNITED THERAPEUTICS Corp UTHR

0001082554-26-000020

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 29, 2026 42.45M sh
Shares Diluted Q1 2026 · Mar 31, 2026 47.2M sh
Shares Diluted Q1 2026 · Mar 31, 2025 48.6M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $1.5B
Stock Repurchased Q1 2026 · Mar 31, 2025 $0
Capex Q1 2026 · Mar 31, 2026 $100.8M
Capex Q1 2026 · Mar 31, 2025 $74.9M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $463.3M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $461.2M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $1.28B
Cash And Equivalents Q1 2026 · Dec 31, 2025 $1.56B
Stockholders Equity Q1 2026 · Mar 31, 2026 $5.9B
Stockholders Equity Q1 2026 · Dec 31, 2025 $7.1B
Stockholders Equity Q1 2026 · Mar 31, 2025 $6.81B
Stockholders Equity Q1 2026 · Dec 31, 2024 $6.44B
Current Liabilities Q1 2026 · Mar 31, 2026 $599.1M
Current Liabilities Q1 2026 · Dec 31, 2025 $560.6M
Total Liabilities Q1 2026 · Mar 31, 2026 $813.1M
Total Liabilities Q1 2026 · Dec 31, 2025 $783.8M
Current Assets Q1 2026 · Mar 31, 2026 $2.87B
Current Assets Q1 2026 · Dec 31, 2025 $3.7B
Total Assets Q1 2026 · Mar 31, 2026 $6.71B
Total Assets Q1 2026 · Dec 31, 2025 $7.88B
Eps Diluted Q1 2026 · Mar 31, 2026 $5.82
Eps Diluted Q1 2026 · Mar 31, 2025 $6.63
Eps Basic Q1 2026 · Mar 31, 2026 $6.32
Eps Basic Q1 2026 · Mar 31, 2025 $7.18
Sga Expense Q1 2026 · Mar 31, 2026 $184.1M
Sga Expense Q1 2026 · Mar 31, 2025 $170.1M
Rd Expense Q1 2026 · Mar 31, 2026 $138.2M
Rd Expense Q1 2026 · Mar 31, 2025 $149M
Net Income Q1 2026 · Mar 31, 2026 $274.9M
Net Income Q1 2026 · Mar 31, 2025 $322.2M
Operating Income Q1 2026 · Mar 31, 2026 $325.8M
Operating Income Q1 2026 · Mar 31, 2025 $382.8M
Gross Profit Q1 2026 · Mar 31, 2026 $648.1M
Gross Profit Q1 2026 · Mar 31, 2025 $701.9M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $133.4M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $92.5M
Revenue Q1 2026 · Mar 31, 2026 $781.5M
Revenue Q1 2026 · Mar 31, 2025 $794.4M